Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SIEMENS HEALTHINEERS AG

(SHL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

SIEMENS HEALTHINEERS : NorldLB gives a Neutral rating

10/07/2021 | 08:35am EST

Analyst Thorsten Strauß from NorldLB research gives the stock a Neutral rating.


© MarketScreener with dpa-AFX Analyser 2021
All news about SIEMENS HEALTHINEERS AG
09:04aBiotechnology firm Freenome raises $300 million in fresh funding
RE
12/06SIEMENS HEALTHINEERS AG : Release of a capital market information
EQ
12/06Siemens AGMunich; Supervisory Board renews the term of office of Ralf Thomas, Managing ..
AQ
12/03Siemens AG - Supervisory Board renews the term of office of Ralf Thomas, Managing Board..
AQ
12/02Siemens Renews CFO's Term Of Office
MT
12/02Siemens Renews Term for CFO Ralf Thomas
DJ
12/02Atos and Siemens to support Morocco in the smart management of its power grid
AQ
12/01Freenome Partners with Siemens Healthineers for Breast Cancer Research
CI
11/29SIEMENS HEALTHINEERS AG : Release of a capital market information
EQ
11/26Siemens AG - Halfway point of 2023 research period for Aspern Smart City Research
AQ
More news
Analyst Recommendations on SIEMENS HEALTHINEERS AG
More recommendations
Financials
Sales 2022 19 879 M 22 361 M 22 361 M
Net income 2022 1 938 M 2 180 M 2 180 M
Net Debt 2022 11 991 M 13 488 M 13 488 M
P/E ratio 2022 36,5x
Yield 2022 1,48%
Capitalization 71 523 M 80 662 M 80 451 M
EV / Sales 2022 4,20x
EV / Sales 2023 3,86x
Nbr of Employees 66 000
Free-Float 24,2%
Chart SIEMENS HEALTHINEERS AG
Duration : Period :
Siemens Healthineers AG Technical Analysis Chart | SHL | DE000SHL1006 | MarketScreener
Technical analysis trends SIEMENS HEALTHINEERS AG
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Last Close Price 63,76 €
Average target price 67,97 €
Spread / Average Target 6,61%
EPS Revisions
Managers and Directors
Bernhard Montag Chief Executive Officer
Jochen Schmitz Chief Financial Officer
Ralf Peter Thomas Chairman-Supervisory Board
Thorsten Opderbeck Head-Technology, Trade & Regional Media
A. Gregory Sorensen Member-Supervisory Board
Sector and Competitors